Search

everythinglearnresearchcommunity

for

Search:↓

Medium-sized particles penetrate hair follicles better than smaller or larger ones, which could improve delivery of skin treatments.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

Hair loss in men is common, treatable, but not curable.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Isotretinoin is highly effective in treating severe acne, rosacea, and gram-negative folliculitis.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Particles around 100 nm can penetrate and stay in hair follicles without passing through healthy skin, making them safe for use in topical products and useful for targeted drug delivery.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

FOXO1 is important for wound healing, but its dysfunction in diabetes can slow the healing process.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Minoxidil boosts hair growth by activating PGHS-1.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.